Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4614-4624
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4614
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4614
Variables | n (%) or median (range) |
Age (years) | 61.0 (28.0-75.0) |
Gender | |
Male | 16 (48.5) |
Female | 17 (51.5) |
Diameter of lesion (cm) | 2.0 (1.0-3.0) |
Distance from the anal verge (cm) | 3.0 (1.0-10.0) |
cT baseline | |
1 | 0 (0.0) |
2 | 9 (27.3) |
3 | 19 (57.6) |
4 | 5 (15.2) |
cN baseline | |
Negative | 8 (24.2) |
Positive | 25 (75.8) |
cM baseline | |
M0 | 31 (93.9) |
M1 | 2 (6.1) |
ycT | |
0 | 21 (63.6) |
1 | 5 (15.2) |
2 | 6 (18.2) |
3 | 1 (3.0) |
4 | 0 (0.0) |
ypT | |
0 | 18 (54.5) |
1 | 6 (18.2) |
2 | 7 (21.2) |
3 | 2 (6.1) |
4 | 0 (0.0) |
Differentiation | |
G1 | 3 (9.1) |
G2 | 29 (87.9) |
G3 | 1(3.0) |
Baseline CEA | |
Normal | 32 (97.0) |
Abnormal | 1 (3.0) |
Interval between NCRT and surgery (week) | 25.4 (8.7-164.4) |
Chemotherapy | |
Cap | 13 (39.4) |
CapeOx | 20 (60.6) |
Surgical duration (minute) | 57.0 (20.0-137.0) |
Blood loss (mL) | 10.0 (5.0-50.0) |
Postoperative hospital stay (days) | 4.0 (1.0-11.0) |
Complication | |
No complication | 26 (78.8) |
With complication | 7 (21.2) |
CD grade | |
Grade I | 1 (3) |
Grade II | 6 (18.2) |
Grade III-IV | 0 (0.0) |
Recurrence | |
No | 31 (93.9) |
Yes | 2 (6.1) |
Metastasis (cM0, n = 31) | |
No | 28 (90.3) |
Yes | 3 (9.7) |
Follow-up time (month) | 42.0 (4.0-93.5) |
- Citation: Chen N, Li CL, Wang L, Yao YF, Peng YF, Zhan TC, Zhao J, Wu AW. Local excision for middle-low rectal cancer after neoadjuvant chemoradiation: A retrospective study from a single tertiary center. World J Gastrointest Oncol 2024; 16(12): 4614-4624
- URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4614.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4614